Anticoagulant

Patients taking oral anticoagulants had a lower risk for dementia/cognitive impairment compared with those not taking oral anticoagulants, according to a study published in HeartRhythm.

The American Heart Association Scientific Sessions had several presentations with major implications for cardiology, most notably the ISCHEMIA and ISCHEMIA-CKD trials, considered to be the most important findings for management of stable ischemic heart disease in more than a decade.

ORLANDO — Apixaban reduced the risk for recurrent venous thromboembolism compared with low-molecular-weight heparin and warfarin, according to results of a large epidemiology study presented at the ASH Annual Meeting and Exposition.

ORLANDO — In this video at the ASH Annual Meeting and Exposition, Thein H. Oo, MD, FRCPE, FACP, reviews a study that showed the addition of aspirin to direct oral anticoagulants for venous thromboembolism or non-valvular atrial fibrillation was linked to an increase in bleeding events.

ORLANDO — The addition of aspirin to direct oral anticoagulant therapy for venous thromboembolism or nonvalvular atrial fibrillation appeared associated with increased rates of bleeding events compared with use of the anticoagulants alone, according to results of a registry-based cohort study presented at ASH Annual Meeting at Exposition.

One in three older adults prescribed Eliquis has used an over-the-counter medication or dietary supplement that may cause a potentially serious interaction, according to researchers.

During a recent webinar, ASH President Roy L. Silverstein, MD, highlighted three “potentially practice-changing” abstracts on venous thromboembolism that will be presented at the upcoming meeting in Orlando, Fla.

The combination of a D-dimer level below 1,000 ng/mL and low clinical pretest probability correctly identified a group of patients at low risk for pulmonary embolism during follow-up, according to results of a prospective study published in The New England Journal of Medicine.

Patients with atrial fibrillation who used warfarin had a higher fracture risk than those who used direct oral anticoagulants, according to a study published in JAMA Internal Medicine.

SAN ANTONIO — Andexxa helped produce high rates of hemostasis in patients with major gastrointestinal bleeding, according to study results presented at the American College of Gastroenterology Annual Meeting.